Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial

Asahi Oshima, Nozomu Kanehama, David van Klaveren, Judith Schlueter, Neil O’ Leary, Kai Ninomiya, Shigetaka Kageyama, Adrian Wlodarczak, Helge Möllmann, Raul Moreno, Milosz Dziarmaga, Manel Sabate, Jacek Legutko, Marc Silvestri, Julien Lemoine, Anirban Choudhury, Hüseyin Ince, Alper Öner, Albert Chinhenzva, Pruthvi C Revaiah, Scot Garg, Marie-angèle Morel, Yoshinobu Onuma, Patrick W Serruys

Open source

DOI
10.1093/ehjqcco/qcag122
Published
2026-07-28
Container
European Heart Journal - Quality of Care and Clinical Outcomes
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjqcco/qcag122,
  title = {Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial},
  author = {Asahi Oshima and Nozomu Kanehama and David van Klaveren and Judith Schlueter and Neil O’ Leary and Kai Ninomiya and Shigetaka Kageyama and Adrian Wlodarczak and Helge Möllmann and Raul Moreno and Milosz Dziarmaga and Manel Sabate and Jacek Legutko and Marc Silvestri and Julien Lemoine and Anirban Choudhury and Hüseyin Ince and Alper Öner and Albert Chinhenzva and Pruthvi C Revaiah and Scot Garg and Marie-angèle Morel and Yoshinobu Onuma and Patrick W Serruys},
  year = {2026},
  journal = {European Heart Journal - Quality of Care and Clinical Outcomes},
  doi = {10.1093/ehjqcco/qcag122},
  url = {https://doi.org/10.1093/ehjqcco/qcag122}
}

RIS

TY  - JOUR
TI  - Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial
AU  - Asahi Oshima
AU  - Nozomu Kanehama
AU  - David van Klaveren
AU  - Judith Schlueter
AU  - Neil O’ Leary
AU  - Kai Ninomiya
AU  - Shigetaka Kageyama
AU  - Adrian Wlodarczak
AU  - Helge Möllmann
AU  - Raul Moreno
AU  - Milosz Dziarmaga
AU  - Manel Sabate
AU  - Jacek Legutko
AU  - Marc Silvestri
AU  - Julien Lemoine
AU  - Anirban Choudhury
AU  - Hüseyin Ince
AU  - Alper Öner
AU  - Albert Chinhenzva
AU  - Pruthvi C Revaiah
AU  - Scot Garg
AU  - Marie-angèle Morel
AU  - Yoshinobu Onuma
AU  - Patrick W Serruys
PY  - 2026
JO  - European Heart Journal - Quality of Care and Clinical Outcomes
DO  - 10.1093/ehjqcco/qcag122
UR  - https://doi.org/10.1093/ehjqcco/qcag122
ER  - 

APA

Oshima, A., Kanehama, N., Klaveren, D. V., Schlueter, J., Leary, N. O., Ninomiya, K., Kageyama, S., Wlodarczak, A., Möllmann, H., Moreno, R., Dziarmaga, M., Sabate, M., Legutko, J., Silvestri, M., Lemoine, J., Choudhury, A., Ince, H., Öner, A., Chinhenzva, A., Revaiah, P. C., Garg, S., Morel, M., Onuma, Y., & Serruys, P. W. (2026). Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trial. European Heart Journal - Quality of Care and Clinical Outcomes. https://doi.org/10.1093/ehjqcco/qcag122

Source records